• Realizing The Benefits Of Bringing The Trial To The Patient

    May 26 | Clinical Research News | During the worst days of the COVID-19 pandemic, drug sponsors, clinical sites, and patients alike discovered the value of in-home services in allowing research studies to proceed while minimizing patients’ potential exposure to the virus from on-site visits. Such services were a lifeline to the research industry. Today, in-home services are being baked into trial protocols not out of dire necessity, but rather out of an appreciation for their value in supporting patient-centric trials with decentralised components. More
  • News and Products from Trialbee, Flatiron, Sanofi, Phesi, Personalis, More

    May 24 | Clinical Research News | Trialbee enhances recruitment strategy; Flatiron and Sanofi set out to redesign the clinical trial experience for sponsors, sites, and patients; and Phesi has published the first edition of its Digital Patient Profile (DPP) catalog. Plus: partnerships for Culmination Bio, Cofactor Genomics, Personalis, Ono Pharmaceuticals, National Cancer Center, and more. More
  • As CVS Slowly Exits Clinical Trial Business, Walgreens Continues Ramp-Up

    May 23 | Clinical Research News | Last week, CVS Health announced its intension to phase out of the clinical trial business with a full exit expected by the end of 2024. In a conversation with Clinical Research News, Walgreens Chief Clinical Trials Officer Ramita Tandon applauds her colleagues at CVS for being the first mover. She is also reassuring Walgreens stakeholders that “we are not going away.” More
  • New Antimicrobial Susceptibility Test Suggests Generic Z-Pak Can Cure Superbugs

    May 18 | Clinical Research News | A new antimicrobial susceptibility testing (AST) method developed by scientists at the University of California, Santa Barbara, resolves the longstanding conflict between what the gold-standard assay says will work and actual patient outcomes when it comes to selecting antibiotics. The alternative AST protocol reveals that antibiotics already widely available on the market can cure superbugs. More
  • Blinded, Randomized Clinical Trial Suggests AI ‘Near-Ready For Prime Time’

    May 16 | Clinical Research News | In a first-of-its-kind, blinded and randomized clinical trial of artificial intelligence (AI) in cardiology, investigators at Cedars-Sinai Medical Center have shown that an “AI assistant” for assessing heart health works even better than sonographers at reading echocardiograms. The software was integrated with the institution’s picture archiving and communication system that securely stores and digitally transmits electronic images. More
  • Data Matters: Creating the Perfect Health Research Cohort

    May 12 | Clinical Research News | Research scientists know that an important foundation of research is cohort creation; many critical decisions are made based on how the cohort is built and designed. Better cohort creation can lead to more accurate findings and better care outcomes. But how do you build a better cohort? It all starts with the research question and the data at hand. More
  • Parkinson’s Disease Trials Need Better Markers Of Cognitive Changes

    May 10 | Clinical Research News | The instruments commonly used to assess cognitive decline in Parkinson’s disease (PD) patients enrolled in neuroprotective clinical trials are “poorly suited to the task,” according to industry consultant Travis Turner, Ph.D., assistant professor and director of the neuropsychology division at Medical University of South Carolina, and senior clinical director for movement disorders at WCG. “I strongly suspect that good interventions have been discarded because [of] the tests that were trying to measure efficacy.” More
  • Predictive Analytics Giving The Lowdown on Clinical Trial Performance

    May 09 | Clinical Research News | A data-agnostic integration platform for optimizing trial planning and conduct hit the streets three years ago, bringing near-real-time insights about every participant, site, country, region, and study to companies struggling to reduce the cost and speed the pace of clinical research. The technology, powered by machine learning, is currently underpinned by data from more than 2,000 trials and over 400,000 healthcare providers. More
View more articles

The Scope of Things podcast explores clinical research and its possibilities, promise, and pitfalls. Clinical Research News Senior writer Deborah Borfitz welcomes guests who are visionaries closest to the topics, but who can still see past their piece of the puzzle. Focusing on game-changing trends and out-of-the-box operational approaches in the clinical research field, the Scope of Things podcast is your no-nonsense, insider’s look at clinical research today.